Guest Speaker

Alexander Birkman: Head of Research Dr. Hubert Trubel: Chief Medical Officer and Head of Clinical Development Pritelivir is currently in clinical trials in more than 70 locations globally.

Join Dr. TJ Cradick, Chief Scientific Officer at Excision Biotherapeutics to learn about Excision Bio pre-clinical work in gene therapy for Herpes Simplex. Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. A recognized expert in genome editing technologies, Dr. Cradick has developed nucleases, as wellContinue reading "Dr. TJ Cradick: Excision Biotherapeutics"

Professor, Vaccine and Infectious Disease Division Dr. Keith Jerome is a renowned virologist whose research focuses on viruses such as herpes simplex, HIV and hepatitis B that persist in their hosts. He studies the ways in which these viruses evade the immune system and potential therapies for these infections. Dr. Jerome and The Jerome LabContinue reading "Dr. Keith Jerome: Fred Hutch Cancer Center"

Professor and Vice Chair for Research, Department of Pediatrics and Microbiology-Immunology. Chief, Division of Pediatric Infectious Diseases Albert Einstein College of Medicine Betsy Herold, M.D. directs a basic and translational research program, which focuses on the prevention of HIV and HSV and other viral infections. Basic research in the lab focuses on the development ofContinue reading "Betsy C. Herold, M.D.: Harold and Muriel Block Chair, Dept. of Pediatrics"

Join for a discussion with Herpes Cure Advocacy medical advisory board member Dr. Gary Richwald. Learn about the latest advances in herpes simplex virus cure, treatment and prevention efforts inContinue reading "Dr. Gary Richwald: Herpes Cure Advocacy"

Herpes Cure Advocacy Meet the Experts series returns this Fall with Dr. Anna Wald and an overview of the clinical pipeline for Herpes. Dr Anna Wald is Professor in the DepartmentContinue reading "Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald"